SciSparc Launches Quantum 3D Protein Modeling Initiative for AI Drug Discovery
Reuters
Oct 23, 2025
SciSparc Launches Quantum 3D Protein Modeling Initiative for AI Drug Discovery
Scisparc Ltd. has announced plans to launch a new initiative aimed at advancing 3D protein modeling using quantum computing technology. The company's board of directors resolved to begin this project on September 16, 2025. The goal is to revolutionize drug discovery by achieving unprecedented accuracy in predicting protein structures and their interactions with potential drugs, which could lead to breakthroughs in structural biology and personalized medicine. Scisparc will form a dedicated research team and collaborate with experts in quantum computing and structural biology to develop these capabilities. The results of this initiative have not yet been presented, as the program is in its initial stages.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scisparc Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9550956-en) on October 23, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.